Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multicenter Study to Assess the Safety and Efficacy of Leuprorelin in the Treatment of Central Precocious Puberty

NCT02427958 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02427958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02427958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multicenter Study to Assess the Safety and Efficacy of Leuprorelin in the Treatment of Central Precocious Puberty
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Completed
Start date
August 7, 2015
Completion date
November 23, 2018
Enrollment
307 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

central precocious puberty